Showing results (2061-2070 of 3,888) with videos related to
Sort By:
Pageof 389
Cancer Biology & Therapy|January 22, 2005
Inhibition of gastric cancer angiogenesis by vector-based RNA interference for Raf-1Fanping Meng, Jie Ding, Na Liu, et al.Cancer Biology & Therapy|November 14, 2003
Activation and suppression of the TRAIL death-receptor pathway in chemotherapy sensitive and resistant follicular lymphoma cellsKlaus W Wagner, Fred King, Ken Nomoto, et al.Cancer Biology & Therapy|January 24, 2004
Targeting vascular and avascular compartments of tumors with C. novyi-NT and anti-microtubule agentsLong H Dang, Chetan Bettegowda, Nishant Agrawal, et al.Cancer Biology & Therapy|January 24, 2004
Regulation of tumor progression by anti-neoplastic T cell responsesScott I AbramsCancer Biology & Therapy|January 17, 2004
A phase II study of topotecan and cyclophosphamide with G-CSF in patients with advanced small cell lung cancerErole M Hobdy, Eric Kraut, Gregory Masters, et al.Cancer Biology & Therapy|January 17, 2004
The Tyr-kinase inhibitor AG879, that blocks the ETK-PAK1 interaction, suppresses the RAS-induced PAK1 activation and malignant transformationHong He, Yumiko Hirokawa, Aviv Gazit, et al.Cancer Biology & Therapy|January 17, 2004
Fibronectin alters cell survival and intracellular signaling of confluent A549 cultures after irradiationN Cordes, C BeinkeCancer Biology & Therapy|January 17, 2004
Expression of inducible Bcl-X(S) in myeloid leukemia: compensatory upregulation of Bcl-X(L) and Bcl-2 prevents apoptosis and chemosensitizationFrank Tacke, Frank C Marini, Shourong Zhao, et al.Cancer Biology & Therapy|February 7, 2004
Upregulation of the androgen receptor during prostate cancer progressionArun Singh, William D FiggCancer Biology & Therapy|February 7, 2004
Targeting aberrant signal transduction pathways in lung cancerJoell J Gills, Courtney A Granville, Phillip A DennisPageof 389